Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 4
1988 1
1989 6
1990 5
1991 2
1992 4
1993 4
1994 3
1995 2
1996 1
1997 5
1998 4
1999 9
2000 8
2001 4
2002 6
2003 5
2004 8
2005 8
2006 11
2007 9
2008 11
2009 8
2010 17
2011 15
2012 23
2013 22
2014 13
2015 30
2016 22
2017 13
2018 17
2019 15
2020 12
2021 20
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

322 results
Results by year
Filters applied: . Clear all
Page 1
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.
Labrecque MP, Coleman IM, Brown LG, True LD, Kollath L, Lakely B, Nguyen HM, Yang YC, da Costa RMG, Kaipainen A, Coleman R, Higano CS, Yu EY, Cheng HH, Mostaghel EA, Montgomery B, Schweizer MT, Hsieh AC, Lin DW, Corey E, Nelson PS, Morrissey C. Labrecque MP, et al. J Clin Invest. 2019 Jul 30;129(10):4492-4505. doi: 10.1172/JCI128212. J Clin Invest. 2019. PMID: 31361600 Free PMC article.
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.
Labrecque MP, Brown LG, Coleman IM, Lakely B, Brady NJ, Lee JK, Nguyen HM, Li D, Hanratty B, Haffner MC, Rickman DS, True LD, Lin DW, Lam HM, Alumkal JJ, Corey E, Nelson PS, Morrissey C. Labrecque MP, et al. Cancer Res. 2021 Sep 15;81(18):4736-4750. doi: 10.1158/0008-5472.CAN-21-0307. Epub 2021 Jul 26. Cancer Res. 2021. PMID: 34312180 Free PMC article.
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.
Kim DH, Sun D, Storck WK, Welker Leng K, Jenkins C, Coleman DJ, Sampson D, Guan X, Kumaraswamy A, Rodansky ES, Urrutia JA, Schwartzman JA, Zhang C, Beltran H, Labrecque MP, Morrissey C, Lucas JM, Coleman IM, Nelson PS, Corey E, Handelman SK, Sexton JZ, Aggarwal R, Abida W, Feng FY, Small EJ, Spratt DE, Bankhead A 3rd, Rao A, Gesner EM, Attwell S, Lakhotia S, Campeau E, Yates JA, Xia Z, Alumkal JJ. Kim DH, et al. Among authors: labrecque mp. Clin Cancer Res. 2021 Sep 1;27(17):4923-4936. doi: 10.1158/1078-0432.CCR-20-4968. Epub 2021 Jun 18. Clin Cancer Res. 2021. PMID: 34145028 Free PMC article.
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.
DeLucia DC, Cardillo TM, Ang L, Labrecque MP, Zhang A, Hopkins JE, De Sarkar N, Coleman I, da Costa RMG, Corey E, True LD, Haffner MC, Schweizer MT, Morrissey C, Nelson PS, Lee JK. DeLucia DC, et al. Among authors: labrecque mp. Clin Cancer Res. 2021 Feb 1;27(3):759-774. doi: 10.1158/1078-0432.CCR-20-3396. Epub 2020 Nov 16. Clin Cancer Res. 2021. PMID: 33199493 Free PMC article.
Irritant-induced asthma.
Labrecque M. Labrecque M. Curr Opin Allergy Clin Immunol. 2012 Apr;12(2):140-4. doi: 10.1097/ACI.0b013e32835143b8. Curr Opin Allergy Clin Immunol. 2012. PMID: 22327170 Review.
Occupational asthma.
Malo JL, Lemière C, Gautrin D, Labrecque M. Malo JL, et al. Among authors: labrecque m. Curr Opin Pulm Med. 2004 Jan;10(1):57-61. doi: 10.1097/00063198-200401000-00010. Curr Opin Pulm Med. 2004. PMID: 14749607 Review.
Effectiveness of vasectomy techniques.
Sokal DC, Labrecque M. Sokal DC, et al. Among authors: labrecque m. Urol Clin North Am. 2009 Aug;36(3):317-29. doi: 10.1016/j.ucl.2009.05.008. Urol Clin North Am. 2009. PMID: 19643234 Review.
322 results